Departamento de Biotecnologia, Faculdade de Ciências e Letras, Universidade Estadual Paulista, Assis, SP, Brasil.
Faculdade de Ciências Biológicas e Ambientais, Universidade Federal da Grande Dourados, Dourados, MS, Brasil.
Braz J Med Biol Res. 2023 Jul 21;56:e12713. doi: 10.1590/1414-431X2023e12713. eCollection 2023.
Mesenchymal stromal/stem cells stem (MSC) have been widely studied due to their great potential for application in tissue engineering and regenerative and translational medicine. In MSC-based therapy for human diseases, cell proliferation is required to obtain a large and adequate number of cells to ensure therapeutic efficacy. During in vitro culture, cells are under an artificial environment and manipulative stress that can affect genetic stability. Several regulatory agencies have established guidelines to ensure greater safety in cell-based regenerative and translational medicine, but there is no specific definition about the maximum number of passages that ensure the lowest possible risk in MSC-based regenerative medicine. In this context, the aim of this study was to analyze DNA damage and chromosome alterations in adipose-derived mesenchymal stromal cells (ADMSC) until the eleventh passage and to provide additional subsidies to regulatory agencies related to number of passages in these cells. Thus, two methods in genetic toxicology were adopted: comet assay and micronucleus test. The comet assay results showed an increase in DNA damage from the fifth passage onwards. The micronucleus test showed a statistically significant increase of micronucleus from the seventh passage onwards, indicating a possible mutagenic effect associated with the increase in the number of passages. Based on these results, it is important to emphasize the need to assess genetic toxicology and inclusion of new guidelines by regulatory agencies to guarantee the safety of MSC-based therapies for human diseases.
间充质基质/干细胞(MSC)因其在组织工程、再生和转化医学中的巨大应用潜力而得到广泛研究。在基于 MSC 的人类疾病治疗中,需要细胞增殖以获得大量足够的细胞,以确保治疗效果。在体外培养过程中,细胞处于人工环境和操纵性应激下,这可能会影响遗传稳定性。一些监管机构已经制定了指南,以确保细胞再生和转化医学的更高安全性,但对于确保基于 MSC 的再生医学中风险最低的最大传代数,尚无具体定义。在这种情况下,本研究的目的是分析脂肪来源的间充质基质细胞(ADMSC)直到第十一代的 DNA 损伤和染色体改变,并为与这些细胞的传代数相关的监管机构提供额外的支持。因此,采用了两种遗传毒性学方法:彗星试验和微核试验。彗星试验结果表明,从第五代开始,DNA 损伤增加。微核试验表明,从第七代开始,微核的数量有统计学意义的增加,表明与传代次数增加相关的可能诱变作用。基于这些结果,重要的是要强调需要评估遗传毒性,并由监管机构纳入新的指南,以保证基于 MSC 的人类疾病治疗的安全性。